Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru (Q28478014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

Wilmer Gianfranco Silva Caso

17 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Antonio Bernabé Ortiz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Alejandro Revilla-Montag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sonia Guillen-Bravo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eduardo Velez-Segovia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andrea Soria-Montoya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Alexandra Nuñez-Garbin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

16 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

e27610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

17 January 2020

copyright license

start time

16 November 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Nutrition, diabetes and tuberculosis in the epidemiological transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Treatment of latent tuberculosis infection in HIV infected persons

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

The prevalence and evolution of anemia associated with tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Antituberculosis drugs and hepatotoxicity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Adverse reactions to first-line antituberculosis drugs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Side effects associated with the treatment of multidrug-resistant tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Tuberculosis and nutrition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Dosage of antituberculous drugs in obese patients.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Obesity and fasting--effects on drug metabolism and drug action in man

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Hepatotoxicity of pyrazinamide: cohort and case-control analyses

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Treatment of pulmonary tuberculosis

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Isoniazid hepatotoxicity among drug users: the role of hepatitis C.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3217998

Drug-induced hepatotoxicity

27 November 2018

1 reference

12 December 2020

Adverse drug reactions associated with first-line anti-tuberculosis drug regimens

1 reference

12 December 2020

Risk factors of side effects of antituberculosis drugs

1 reference

12 December 2020

[Systematic review of anti-tuberculosis drug induced adverse reactions in China]

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0027610

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

release_erso6javz5bgvlxeumjn4utxfy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/erso6javz5bgvlxeumjn4utxfy

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22110689%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference